Clinical study on NB-UVB combined with Tuibai Decoction in the treatment of vitiligo
Wang Jian,Xie Yong,Sheng Guorong
DOI: https://doi.org/10.13412/j.cnki.zyyl.2013.02.071
2013-01-01
Abstract:Objective: To investigate the clinical effect and safety of narrow-band ultraviolet B(NB-UVB) patial irradiation combined with Tuibai Decoction taken orally in the treatment of vitiligo.Methods:120 cases of vitiligo patients were randomly divided into 3 groups,40 cases in each group,the treatment group treated with NB-UVB irradiation,the initial dose was 0.5J/cm2,2 times per week,each dose increasing 10%~20%,and maintain the dose when erythema appeared,taken orally of Tuibai Decoction,2 times per day.Control groupⅠmerely took Tuibai Decoction orally;Control group II only use NB-UVB partial irradiation,methods were the same with the treatment group.3 groups were treated for 12 weeks continuously,and the clinical effect were evaluated respectively in the treatment of 4,8 and 12 weeks.Results: The effect ratios of treatment group,control groupⅠ,and control groupⅡwere 77.5%,55% and 47.5% respectively after 12 weeks of treatment.The differences were statistically significant when treatment group compared with control groupⅠand control groupⅡ.(P<0.05or P<0.01).Color-recovering starting time of treatment group was significantly earlier than control groupⅠand control groupⅡ,and the differences were statistically significant(P < 0.01).The incidence of adverse reaction of treatment group was 12.5%,7.5% in control groupⅠand 12.5% in control group Ⅱ,the difference was not statistically significant when the 3 groups compared with each other(P > 0.05).Conclusion: Clinical effect of NB-UVB partial irradiation combined with Tuibai Decoction taken orally in the treatment of vitiligo is definite,with good safety,worthy of clinical popularization and application in the department of dermatology.